Sponsored by:
Discover Why Douglas Softgels Are the Smarter Choice for Oral Drug Formulation
From improved stability and shelf-life to enhanced patient compliance, softgel technology is redefining oral medicines.
Pharmaceutical developers face ongoing challenges with bioavailability, stability, and safety in oral dosage forms. Traditional capsules and tablets often fall short, limiting absorption, creating safety risks for operators, or failing to meet consumer preferences.
That’s where Douglas CDMO brings unmatched expertise in soft gel formulations.
In This Whitepaper, You’ll Learn How Softgels Work:
- Boost Bioavailability – oil-based formulations enable higher absorption of poorly soluble APIs, often requiring less active ingredient.
- Protect Stability & Extend Shelf-Life – sealed gelatin shells shield actives from air and light, while the oil fill protects against oxidation.
- Enhance Patient Compliance – soft, smooth textures make swallowing easier, with higher consumer preference compared to tablets.
- Support Safer Manufacturing – encapsulation minimizes dust and operator exposure to toxic compounds.
Why Partner with Douglas CDMO?
Douglas CDMO is recognized globally for its world-class expertise in softgel technology and long-standing success in highly regulated markets. With proven track records in developing novel and generic compounds, the team provides end-to-end support:
- Early formulation design for bioavailability and stability
- Development through first-in-human trials to commercial supply
- Rigorous quality control, safety, and compliance protocols
- Advanced technology and experienced operators ensure consistent market quality
Your Roadmap to Smarter Formulations
Whether you’re exploring softgels for the first time or seeking a trusted partner to scale production, Douglas CDMO provides the technical, regulatory, and manufacturing expertise to bring your oral drug product to market successfully.
